
Race Oncology Investor Relations Material
Latest events

AGM 2024
Race Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Race Oncology Limited
Access all reports
Race Oncology Limited is an Australian-based pharmaceutical company focused on the development and commercialization of oncology therapies. The company is dedicated to researching and advancing treatments for cancer, particularly through its drug discovery and development programs. Race Oncology employs precision medicine approaches and targets specific cancer-related pathways to address unmet needs in cancer care. The company is headquartered in Sydney, Australia, and its shares are listed on the ASX.
Key slides for Race Oncology Limited


Investor Presentation
Race Oncology Limited


Investor Presentation
Race Oncology Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
RAC
Country
🇦🇺 Australia